ATE367159T1
Immune response modifier compounds for treatment of th2 mediated and related diseases
Abstract
Immune response modifier compounds-imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, and 1,2-bridged imidazoquinoline amines-are useful for the treatment of TH2 mediated diseases by administering a therapeutically effective amount of such compounds in order to inhibit TH2 immune response, suppress IL-4/IL-5 cytokine induction and eosinophilia, as well as enhance TH1 immune response.
Term
Term ended
Projected expiry passed 24 October 2017, 8.9 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
2 priority claims, no other members on record
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 2930196 | United States of America | P | |
| 4533197 | United States of America | P |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 97946484
Titles2
- German
- VERBINDUNGEN, DIE DIE IMMUNANTWORT VERÄNDERN, ZUR BEHANDLUNG VON TH2-VERMITTELTEN UND -VERWANDTEN KRANKHEITEN
- English
- COMPOUNDS THAT ALTER THE IMMUNE RESPONSE FOR THE TREATMENT OF TH2-MEDIATED AND RELATED DISEASES
Classification
- CPC, 16
- A61K31/437
- A61K31/47
- A61K31/4745
- A61K31/4748
- A61P11/06
- A61P29/00
- A61P31/00
- A61P31/04
- A61P31/08
- A61P31/10
- A61P33/00
- A61P33/02
- A61P37/00
- A61P37/02
- A61P37/08
- Y02A50/30
- IPC, 11
- C07D471 04
- A61K31 437
- A61K31 47
- A61K31 4745
- A61K31 4748
- A61P11 06
- A61P31 00
- A61P37 02
- A61P37 08
- C07D471 14
- C07D471 16